Insider Buying: Chemours (NYSE:CC) Insider Acquires $30,050.55 in Stock

The Chemours Company (NYSE:CC) insider Calderon Gerardo Familiar acquired 1,935 shares of Chemours stock in a transaction that occurred on Wednesday, August 12th. The shares were purchased at an average price of $15.53 per share, for a total transaction of $30,050.55. Following the transaction, the insider directly owned 58,547 shares in the company, valued at $909,234.91. The trade was a 3.42% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Chemours Price Performance

Shares of CC opened at $15.81 on Friday. The Chemours Company has a 12-month low of $10.44 and a 12-month high of $28.67. The business has a 50-day simple moving average of $18.54 and a two-hundred day simple moving average of $20.00. The company has a quick ratio of 0.88, a current ratio of 1.66 and a debt-to-equity ratio of 18.98. The stock has a market cap of $2.38 billion, a PE ratio of -8.28 and a beta of 1.43.

Chemours (NYSE:CC) last posted its earnings results on Tuesday, August 4th. The specialty chemicals company reported $0.42 EPS for the quarter, missing the consensus estimate of $0.49 by ($0.07). Chemours had a negative net margin of 5.00% and a positive return on equity of 60.64%. The firm had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.65 billion. During the same quarter in the prior year, the business posted ($2.54) earnings per share. Chemours’s revenue for the quarter was down 1.5% compared to the same quarter last year. Analysts anticipate that The Chemours Company will post 0.88 earnings per share for the current fiscal year.

Chemours Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Friday, August 14th will be paid a $0.0875 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $0.35 annualized dividend and a dividend yield of 2.2%. Chemours’s dividend payout ratio is currently -18.32%.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. BMO Capital Markets cut their target price on shares of Chemours from $26.00 to $18.00 and set an “outperform” rating on the stock in a research report on Thursday. JPMorgan Chase & Co. dropped their price target on shares of Chemours from $22.00 to $15.00 and set a “neutral” rating for the company in a research note on Thursday. Royal Bank Of Canada dropped their price target on shares of Chemours from $26.00 to $22.00 and set an “outperform” rating for the company in a research note on Thursday, August 6th. Morgan Stanley set a $18.00 price target on shares of Chemours in a report on Monday, August 10th. Finally, The Goldman Sachs Group reissued a “neutral” rating and issued a $17.00 price objective on shares of Chemours in a research note on Thursday. Five analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $20.10.

Trending Headlines about Chemours

Here are the key news stories impacting Chemours this week:

• Positive Sentiment: Chemours is expanding its low-GWP Opteon refrigerant portfolio to address rising cooling demand from AI-driven data centers. The initiative could support growth in a higher-demand market while aligning with customers’ decarbonization goals. Zacks article on Chemours refrigerants for data centers
• Positive Sentiment: CEO Denise Dignam bought 3,378 shares for approximately $50,500, while insider Gerardo Familiar Calderon purchased 1,935 shares for roughly $30,000. The open-market purchases may suggest that insiders view the recent share-price weakness as an opportunity. SEC filing on CEO purchase SEC filing on insider purchase
• Neutral Sentiment: BMO Capital Markets cut its price target from $26 to $18 but maintained an “outperform” rating, leaving implied upside while signaling reduced expectations. The broader analyst consensus remains “hold,” with an average target near $20.10.
• Negative Sentiment: A securities-fraud investigation involving Chemours was announced, creating a potential legal and reputational overhang for shareholders. The announcement does not establish wrongdoing, but it may increase uncertainty around the company.
• Negative Sentiment: JPMorgan lowered its price target from $22 to $15 and kept a “neutral” rating, while Zacks Research downgraded the stock from “strong buy” to “strong sell.” These actions reinforce concerns following Chemours’ recent quarterly EPS and revenue misses. Benzinga report on JPMorgan target cut Zacks rating report

Institutional Trading of Chemours

Large investors have recently bought and sold shares of the business. Atlas Capital Advisors Inc. bought a new position in shares of Chemours in the 4th quarter worth about $26,000. Aster Capital Management DIFC Ltd bought a new stake in shares of Chemours during the 4th quarter valued at about $28,000. Covestor Ltd boosted its position in shares of Chemours by 204.7% during the 4th quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock valued at $31,000 after purchasing an additional 1,748 shares in the last quarter. Eurizon Capital SGR S.p.A. acquired a new stake in Chemours during the fourth quarter worth approximately $31,000. Finally, Rothschild Investment LLC grew its stake in Chemours by 87.0% during the fourth quarter. Rothschild Investment LLC now owns 2,698 shares of the specialty chemicals company’s stock worth $32,000 after purchasing an additional 1,255 shares during the period. 76.26% of the stock is currently owned by institutional investors and hedge funds.

About Chemours

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.